Disclosure 0001104659-26-105101-2

SEC FORM 4

$146,572.56

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Disposition (code F) of 17,702 shares at $8.28 per share.

Reporting Person Vogt Frederick G · Officer Title Interim CEO & General Counsel · Transaction Code F

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001104659-26-105101 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "IOVANCE BIOTHERAPEUTICS, INC. (IOVA)." Disclosed 2026-09-03. https://desqlong.com/cards/0001104659-26-105101-2 (retrieved 2026-09-26).